About Frank Troxell

This author has not yet filled in any details.
So far Frank Troxell has created 3 blog entries.

NuMedii Announces Strategic Research Collaboration with Two Leading Academic Research Institutions Utilizing Single-Cell Sequencing to Identify Precision Therapeutics for IPF

By | 2018-07-10T07:53:58+00:00 July 10th, 2018|

SAN MATEO, Calif., July 10, 2018 – NuMedii, Inc., today announced the formation of a strategic research collaboration with Yale School of Medicine and Brigham and Women’s Hospital with the goal of utilizing single-cell sequencing to identify novel precision therapies and biomarkers in idiopathic pulmonary fibrosis (IPF). An orphan disease, IPF is a chronic, progressive [...]

NuMedii Expands Board of Directors and Scientific Advisory Board with the Addition of Two Oncology Experts

By | 2018-07-09T09:07:47+00:00 June 20th, 2018|

MENLO PARK, Calif., June 20, 2018 – NuMedii, Inc., today announced an expansion of its Board of Directors with the appointment of Athena M. Countouriotis, MD. In addition, Zemin Zhang, PhD, has joined the company’s Scientific Advisory Board. Drs. Countouriotis and Zhang are two industry leaders with expertise in cancer clinical development, and genomics and [...]

World’s Leading Lung Disease Experts Join NuMedii’s Idiopathic Pulmonary Fibrosis Advisory Board

By | 2018-07-09T09:11:38+00:00 January 8th, 2018|

MENLO PARK, Calif., January 8, 2018 – NuMedii, Inc. today announced the formation of an Idiopathic Pulmonary Fibrosis (IPF) Advisory Board consisting of the world’s leading experts in interstitial lung disease: Naftali Kaminski, MD; David A. Schwartz, MD; Kevin Brown, MD; Toby Maher, MD, PhD; Gisli Jenkins, MD, PhD; Zea Borok, MD; and, Paul Wolters, [...]